Physical Therapy without Limits

OneStep has developed a comprehensive platform for remote physical therapy.
Leading providers all across the US – from PT providers to orthopedic surgeons to medical device companies – partner with OneStep to evolve from intermittent, clinic-based care to unbounded care that meets the patients wherever they are.

Tyto Care is developing the first FDA-approved, full stack software platform and handheld device to enable anyone, anywhere to perform an accurate physical examination for remote diagnosis at clinical-level data quality. Representing the next generation of telehealth technology, this platform powers modern health systems around the world.

As digital data becomes the key driver of healthcare initiatives and workflows, there’s growing risk of patient information being leaked, exposed, and exploited. Protenus helps hospitals protect patient privacy in electronic medical records by using machine intelligence to identify and apply clinical context and detect HIPAA violations in real time.

Phantom is a neurotechnology company, spun out of the lab at The Johns Hopkins University School of Medicine, that is enabling lifelike control of robotic orthopedic technologies, such as prosthetic limbs and exoskeletons.

Mellie puts everything you need to plan and care for your elders all in one place. We build a personalized care plan for you to plan care, find trusted resources, and provide a dedicated care coordinator to help navigate the entire process.

Mana.bio is an AI based drug delivery startup, facilitating rapid “Design-Build-Test-Learn” cycles for identifying likely drug delivery vehicles for given therapeutic payloads.

Founded by serial entrepreneurs in the precision medicine space, Nest Genomics is building a longitudinal genomic record for providers and patients to manage their genetic data for life.

Phrase Health are empowering teams with EHR data and collaborative tools to drive clinical quality measures and outcomes.

C2i Genomics is the first company to offer post-surgery monitoring of cancer recurrence and progression by analyzing subtle changes in the pattern of the tumor’s DNA.